Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1103)

Milan, Lombardy 20133

1 studies enrolling now · 1 studies all time

What they study most

Prostatic Neoplasms, Castration-Resistant

Studies at this site

• Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A) — Recruiting now